Bader el-Din, Noha G <br/><br/>
Human cytomegalovirus infection inhibits response of chronic hepatitis-C-virus-infected patients to interferon-based therapy.  [electronic resource] 

 -  Journal of gastroenterology and hepatology  Jan 2011 
 - 55-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1440-1746 
<br/><br/><label>Standard No.: </label>10.1111/j.1440-1746.2010.06319.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Viral--blood<br/>Antiviral Agents--therapeutic use<br/>Cytomegalovirus--genetics<br/>Cytomegalovirus Infections--complications<br/>DNA, Viral--blood<br/>Disease Progression<br/>Drug Therapy, Combination<br/>Egypt<br/>Female<br/>Genotype<br/>Hepacivirus--genetics<br/>Hepatitis C Antibodies--blood<br/>Hepatitis C, Chronic--complications<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Liver Cirrhosis--virology<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Odds Ratio<br/>Polyethylene Glycols--therapeutic use<br/>RNA, Viral--blood<br/>Recombinant Proteins<br/>Recurrence<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Ribavirin--therapeutic use<br/>Time Factors<br/>Treatment Outcome<br/>Viral Envelope Proteins--genetics<br/>Viral Load<br/>Virus Activation